Get the Stockscreener App
0.7136
1.84%
-0.0134
After Hours:
.72
0.0064
+0.90%
Ocean Biomedical Inc stock is traded at $0.7136, with a volume of 17,573.
It is down -1.84% in the last 24 hours and down -24.88% over the past month.
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.
See More
Previous Close:
$0.727
Open:
$0.735
24h Volume:
17,573
Relative Volume:
0.32
Market Cap:
$23.91M
Revenue:
-
Net Income/Loss:
$-82.19M
P/E Ratio:
-0.1859
EPS:
-3.839
Net Cash Flow:
$-8.35M
1W Performance:
+3.42%
1M Performance:
-24.88%
6M Performance:
-51.46%
1Y Performance:
-30.04%
1-Day Range:
$0.69
$0.735
1-Week Range:
$0.68
$0.76
52-Week Range:
$0.52
$7.79
Ocean Biomedical Inc Stock (OCEA) Company Profile
Name
Ocean Biomedical Inc
Sector
Industry
Phone
(646) 908-2658
Address
515 MADISON AVE SUITE 8078, NEW YORK
Compare OCEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.7136 | 23.91M | 0 | -82.19M | -8.35M | -3.839 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Ocean Biomedical Inc Stock (OCEA) Latest News
Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Mov - GuruFocus.com
Ocean Biomedical faces Nasdaq delisting - Providence Business News
Ocean Biomedical Inc Com (OCEA) reports earnings - Quartz
Ocean Biomedical, Inc. Announces Receipt of Notice from - GlobeNewswire
Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com
Ocean Biomedical Faces Nasdaq Delisting Threat - TipRanks
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - The Manila Times
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - GlobeNewswire Inc.
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
CO2 Energy Transition Corp. Announces Closing of Previously Announced IPO and Full Exercise of Over-allotment - EIN News
BW LPG takes delivery of vessel BW Capella - MSN
Class Action Lawsuit Against Bumble Inc. (NASDAQ:BMBL) - MSN
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily
BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com
Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
Ocean Biomedical appoints interim CEO amid executive shift - Investing.com India
Ocean Biomedical appoints interim CEO amid executive shift By Investing.com - Investing.com South Africa
Ocean Biomedical receives Nasdaq’s delisting letter - MSN
Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services - The Manila Times
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter - GlobeNewswire
Taipei showcases cutting-edge medical devices & diagnostics at Medica 2024 - healthcare-in-europe.com
Ocean Biomedical secures 22% Virion stake with $9 million deal - Investing.com India
Ocean Biomedical secures 22% Virion stake with $9 million deal By Investing.com - Investing.com South Africa
Molecure inks $32 million deal with Ocean Biomedical for cancer therapy - Investing.com India
Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors. - The Manila Times
Molecure (WSE: MOC) and Nasdaq-listed biotechnology company - GlobeNewswire
Molecure S.A. and Ocean Biomedical Inc. Sign an Exclusive Licensing Agreement for the Development and Commercialization of Selective YKL-40 inhibitors - Marketscreener.com
CAE Inc. (CAE): An Undervalued Foreign Stock to Buy According to Analysts - Yahoo Finance UK
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of September 2024 - EIN News
Casella Waste Systems, Inc. to Host Conference Call on Its Third Quarter 2024 Results - EIN News
Kaltura to Announce Financial Results for Third Quarter 2024 on Wednesday, November 6, 2024 - EIN News
Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your - EIN News
Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for Investors – Contact Levi & - EIN News
DOMINO’S PIZZA, INC. (NYSE: DPZ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Domino’s Pizza, Inc. Investors - EIN News
BioPhotonics Conference 2024 - Photonics Spectra
Ocean Outdoor (LON:OOUT) Trading Up 0.7% - Defense World
Angry Bank of America customers report outages, zero account balances across the country - Yahoo News Canada
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 - The Manila Times
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication - GlobeNewswire
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses - GlobeNewswire
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Update - Defense World
Fralin Biomedical Institute Award Supports Innovation in Brain Cancer Treatment - The Roanoke Star
AB Science provides an update on the microtubule program AB8939 and in particular the ability of AB8939 to generate response on MECOM rearrangement - Yahoo Finance UK
IPO News: Everything you need to know about BioAge Labs’ IPO - AlphaStreet
Blue Ocean Corporation earns global recognition with 2024 ASCM award of excellence - Khaleej Times
OceanFirst Financial (NASDAQ:OCFC) Hits New 52-Week High at $18.97 - MarketBeat
Delisting of Securities of OceanTech Acquisitions I Corp.; OCA Acquisition Corp.; Assure Holdings Corp.; Selina Hospitality PLC; Maquia Capital Acquisition Corporation; ToughBuilt Industries, Inc.; SunPower Corporation; Meta Materials Inc.; Talis Biomedical - StockTitan
What's Going On With Odyssey Marine Exploration Stock? - Benzinga
Ocean Biomedical Inc Stock (OCEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):